Petros Pharmaceuticals, Inc. Dividends Payable
Petros Pharmaceuticals, Inc. (PTPI) had Dividends Payable of $2.31 million as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:DividendsPayableCurrentAndNoncurrent · last filed 2025-03-31
- 2024-12-31: Dividends Payable $2.31M.
- 2024-03-31: Dividends Payable $595.50K.
- 2023-12-31: Dividends Payable $821.46K.
| Period end | Dividends Payable |
|---|---|
| 2024-12-31 | $2.31M 10-K · filed 2025-03-31 |
| 2024-03-31 | $595.50K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $821.46K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |